Aker Solutions OL (0QXP)
London Exchange · UK · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 36.98 |
|---|---|
| 52-week range | 27.57 – 48.36 |
| Return, 1 month / 3 months | −11.5% / −14.3% |
| Return, 1 year / 3 years | +43.8% / +92.7% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -20.2% |
| Average daily value traded | 1.12M NOK |
| Dividend yield | 9.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aker Solutions is a Norwegian engineering and technology company that supplies equipment and services to the energy industry. It designs and builds subsea production systems, platform and topside equipment, and provides field development, engineering and maintenance services. Its customers are oil and gas operators and energy companies working offshore and onshore around the world. The company is based in Oslo, Norway, and its work spans the full life of energy projects, from early engineering studies through construction support and later modification and upkeep of installations.
Aker Solutions OL trades under the code 0QXP on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aker Solutions OL (0QXP) trades on the London Exchange in UK. It last closed at NOK 36.98 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,859 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 43.8% and over the last three months it fell 14.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.8% | ||
| From 52-week high | -22.6% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.3% | ||
| 6-month return | -8.5% | ||
| 12-month return, skipping the last month | 62.4% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.2% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.12M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 9.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −6.0% |
|---|---|
| 1 month | −11.5% |
| 3 months | −14.3% |
| 6 months | −8.5% |
| 1 year | +43.8% |
| 3 years | +92.7% |
| 5 years | +263.8% |
Signals
| 50-day / 200-day average | 41.66 / 40.54 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Apr 2026 | NOK 3.6000 |
| 29 Apr 2025 | NOK 3.3000 |
| 25 Nov 2024 | NOK 21.0000 |
| 12 Apr 2024 | NOK 2.0000 |
| 14 Apr 2023 | NOK 1.0000 |
| 8 Apr 2022 | NOK 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.